IGHE and food allergy: In an ovalbumin food allergy murine model, oral administration of transforming growth factor-beta (TGF-β) allowed acquisition of ovalbumin tolerance, which was assessed by a decrease in ovalbumin specific IgE and IgG1 antibodies and T-cell reactivity, and confirmed by a reduction in the immediate-type skin reaction [27].